Summary & Overview
CPT 0632T: Ultrasound-Guided Pulmonary Artery Nerve Interruption
CPT code 0632T identifies a minimally invasive, ultrasound-guided procedure to interrupt the pulmonary artery nerve supply, including required imaging guidance and right heart catheterization. This emerging interventional cardiology service is notable for its potential role in treating pulmonary vascular or autonomic conditions and for the procedural complexity and resource use it entails. Nationally, accurate coding and coverage determination for this procedure affect hospital outpatient workflows, payer-provider contract terms, and patient access to specialized interventions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines coverage and reimbursement considerations across major national payers, highlights benchmarking elements for hospital and ambulatory surgical settings, and summarizes the clinical and procedural context necessary for billing and authorization processes.
Readers will learn the clinical scope and included services for CPT code 0632T, typical sites of service, and what elements are commonly bundled into the code. The report also examines payer coverage patterns, common administrative issues affecting claim adjudication, and key metrics used in benchmarking utilization and reimbursement. Data not available in the input is clearly noted where applicable.
Billing Code Overview
CPT code 0632T describes a minimally invasive, ultrasound-guided procedure that interrupts the pulmonary artery nerve supply. The service includes the imaging guidance and right heart catheterization necessary to complete the intervention.
-
Service type: Minimally invasive endovascular/interventional cardiology procedure
-
Typical site of service: Hospital outpatient department or specialized interventional suite
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) who remains symptomatic despite optimized medical therapy (e.g., prostacyclins, endothelin receptor antagonists, phosphodiesterase-5 inhibitors) and is evaluated for interventional options. The patient presents with progressive exertional dyspnea, exercise intolerance and right-sided heart strain on imaging and echocardiography. Right heart catheterization confirms elevated pulmonary artery pressures and pulmonary vascular resistance. After multidisciplinary team review (pulmonology, cardiology, interventional cardiology / interventional pulmonology, and anesthesia), the patient is scheduled for a minimally invasive ultrasound-guided pulmonary artery denervation procedure.
Workflow summary:
-
Pre-procedure: Informed consent, review of prior imaging, optimization of anticoagulation, baseline labs, and transthoracic echocardiogram. Anesthesia evaluation (typically monitored anesthesia care or general anesthesia) and vascular access planning are completed.
-
Intra-procedure: The provider obtains venous access, performs right heart catheterization for hemodynamic measurements, uses fluoroscopic and/or intravascular ultrasound guidance to position the catheter in the pulmonary artery, and delivers targeted ultrasound energy to interrupt pulmonary artery nerve fibers. Imaging guidance and hemodynamic monitoring are integral and are included in the service.
-
Post-procedure: The patient is observed in a monitored setting for hemodynamic stability, access-site management, and potential complications (bleeding, arrhythmia, pulmonary artery injury). Follow-up includes repeat hemodynamics and clinical reassessment to gauge symptomatic and functional improvement.